Literature DB >> 15132254

Management of spasticity in children with cerebral palsy.

Ann H Tilton1.   

Abstract

As one component of the upper motor neuron syndrome, spasticity can have a significant functional impact on the child with cerebral palsy. Treatment planning requires the determination that excess tone interferes with some aspect of function, comfort, or care, and takes into consideration carefully devised goals that meet the needs of the patient and the caregiver. Treatment options include physical therapy, oral medications, chemodenervation with botulinum toxin or phenol, rhizotomy, intrathecal baclofen, and orthopedic surgery. The uses and limitations of each is discussed, and evidence for efficacy in cerebral palsy is reviewed.

Entities:  

Mesh:

Year:  2004        PMID: 15132254     DOI: 10.1016/j.spen.2004.01.008

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  14 in total

Review 1.  New clinical and research trends in lower extremity management for ambulatory children with cerebral palsy.

Authors:  Diane L Damiano; Katharine E Alter; Henry Chambers
Journal:  Phys Med Rehabil Clin N Am       Date:  2009-08       Impact factor: 1.784

Review 2.  Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-06

Review 3.  Pharmacologic interventions for reducing spasticity in cerebral palsy.

Authors:  Dilip R Patel; Olufemi Soyode
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

Review 4.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

5.  Hypertonia in children: how and when to treat.

Authors:  Terence D Sanger
Journal:  Curr Treat Options Neurol       Date:  2005-11       Impact factor: 3.598

6.  Intrathecal baclofen pump for spasticity: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-05-01

7.  Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment.

Authors:  Herbert R Henney; Michael Chez
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

8.  Acupuncture for the treatment of spasticity after stroke: a meta-analysis of randomized controlled trials.

Authors:  Si-Woon Park; Sook-Hee Yi; Jung Ah Lee; Pil Woo Hwang; Hyun Cheol Yoo; Kyoung Sook Kang
Journal:  J Altern Complement Med       Date:  2014-09       Impact factor: 2.579

Review 9.  Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  M R Delgado; D Hirtz; M Aisen; S Ashwal; D L Fehlings; J McLaughlin; L A Morrison; M W Shrader; A Tilton; J Vargus-Adams
Journal:  Neurology       Date:  2010-01-26       Impact factor: 9.910

10.  Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A.

Authors:  Moshe Jakubowski; Peter J McAllister; Zahid H Bajwa; Thomas N Ward; Patty Smith; Rami Burstein
Journal:  Pain       Date:  2006-10-25       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.